• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗环瓜氨酸肽抗体在老年起病类风湿关节炎和风湿性多肌痛鉴别诊断中的临床应用

Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.

作者信息

Lopez-Hoyos M, Ruiz de Alegria C, Blanco R, Crespo J, Peña M, Rodriguez-Valverde V, Martinez-Taboada V M

机构信息

Immunology Service, Hospital Universitario Marqués de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

出版信息

Rheumatology (Oxford). 2004 May;43(5):655-7. doi: 10.1093/rheumatology/keh143. Epub 2004 Feb 17.

DOI:10.1093/rheumatology/keh143
PMID:14970400
Abstract

BACKGROUND

In a significant number of patients the differential diagnosis between elderly-onset rheumatoid arthritis (EORA) and polymyalgia rheumatica (PMR) is very difficult because of the lack of specific serum markers. Anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) have recently been shown to be highly specific for rheumatoid arthritis (RA). This is the first study addressing the utility of these antibodies in the differential diagnosis between EORA and PMR.

METHODS

Serum samples from 57 EORA patients and 49 PMR patients were studied for the presence of anti-CCP Abs and rheumatoid factor (RF). As controls, samples from 41 RA patients (age at onset <60 yr) and 24 aged healthy subjects were analysed.

RESULTS

Sixty-five per cent of EORA patients had anti-CCP Abs, whereas none of the PMR patients or the aged healthy subjects was positive for those antibodies. Ten of the EORA patients started with polymyalgic symptoms and two of them were positive for anti-CCP Abs. Interestingly, there was a significant correlation between anti-CCP Abs and RF in EORA but not in young RA patients.

CONCLUSIONS

The presence of anti-CCP Abs in a patient with clinical symptoms of PMR must be interpreted as highly suggestive of EORA.

摘要

背景

由于缺乏特异性血清标志物,在相当数量的患者中,老年发病的类风湿关节炎(EORA)和风湿性多肌痛(PMR)的鉴别诊断非常困难。抗环瓜氨酸肽抗体(抗CCP抗体)最近被证明对类风湿关节炎(RA)具有高度特异性。这是第一项探讨这些抗体在EORA和PMR鉴别诊断中的效用的研究。

方法

研究了57例EORA患者和49例PMR患者的血清样本中抗CCP抗体和类风湿因子(RF)的存在情况。作为对照,分析了41例RA患者(发病年龄<60岁)和24例老年健康受试者的样本。

结果

65%的EORA患者有抗CCP抗体,而PMR患者或老年健康受试者中无一例该抗体呈阳性。10例EORA患者最初表现为多肌痛症状,其中2例抗CCP抗体呈阳性。有趣的是,EORA患者中抗CCP抗体与RF之间存在显著相关性,而年轻RA患者中则不存在。

结论

PMR临床症状患者中抗CCP抗体的存在必须被解释为高度提示EORA。

相似文献

1
Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.抗环瓜氨酸肽抗体在老年起病类风湿关节炎和风湿性多肌痛鉴别诊断中的临床应用
Rheumatology (Oxford). 2004 May;43(5):655-7. doi: 10.1093/rheumatology/keh143. Epub 2004 Feb 17.
2
The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.抗环瓜氨酸肽抗体在老年起病的类风湿关节炎和风湿性多肌痛鉴别诊断中的作用。
Clin Rheumatol. 2006 Nov;25(6):854-7. doi: 10.1007/s10067-005-0188-8. Epub 2006 Mar 2.
3
[Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].[环瓜氨酸肽抗体(抗CCP)以及用于类风湿关节炎血清学诊断的其他一些参数]
Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):163-70.
4
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.抗环瓜氨酸肽抗体对极早期类风湿关节炎的诊断效用
J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.
5
Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.抗环瓜氨酸肽抗体可区分慢性乙型肝炎病毒(HBV)感染患者中HBV相关关节病与合并的类风湿关节炎。
J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.
6
Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.类风湿因子和抗环瓜氨酸肽抗体可将类风湿关节炎与早期关节炎患者的未分化多关节炎区分开来。
J Rheumatol. 2002 Oct;29(10):2074-6.
7
Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.老年发病类风湿关节炎患者的促炎细胞因子谱:与年轻发病疾病的比较。
Gerontology. 2009;55(3):250-8. doi: 10.1159/000164393. Epub 2008 Oct 13.
8
[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].抗环瓜氨酸肽(anti-CCP)抗体在类风湿关节炎血清学诊断及疾病活动度评估中的作用
Mikrobiyol Bul. 2008 Oct;42(4):669-74.
9
Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.抗环瓜氨酸肽抗体、抗瓜氨酸抗体以及 IgM 和 IgA 类风湿因子与类风湿关节炎疾病活动血清学参数的关联
Ann N Y Acad Sci. 2005 Jun;1050:295-303. doi: 10.1196/annals.1313.031.
10
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.特异性自身抗体先于类风湿关节炎症状出现:一项对献血者的系列检测研究
Arthritis Rheum. 2004 Feb;50(2):380-6. doi: 10.1002/art.20018.

引用本文的文献

1
The Characteristics and Management Considerations of Late-onset Rheumatoid Arthritis.迟发性类风湿关节炎的特征及管理考量
Intern Med. 2024 Dec 15;63(24):3267-3269. doi: 10.2169/internalmedicine.3786-24. Epub 2024 May 2.
2
Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis.老年发病的类风湿关节炎与风湿性多肌痛:发病机制的差异
Front Med (Lausanne). 2023 Jan 12;9:1083879. doi: 10.3389/fmed.2022.1083879. eCollection 2022.
3
[Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study].
老年起病类风湿关节炎患者心血管疾病的临床特征及危险因素:一项大型横断面临床研究
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1040-1047. doi: 10.19723/j.issn.1671-167X.2020.06.009.
4
Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations.日本人群中HLA - DRB1基因型与早发型和晚发型类风湿关节炎的关联。
Medicine (Baltimore). 2019 Nov;98(48):e18218. doi: 10.1097/MD.0000000000018218.
5
Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care.初级卫生保健中风湿性多肌痛诊断及分类标准的有效性
Rheumatol Adv Pract. 2019 Aug 27;3(2):rkz033. doi: 10.1093/rap/rkz033. eCollection 2019.
6
The Difficult Rheumatology Diagnosis.疑难风湿病诊断
Ethiop J Health Sci. 2018 Jan;28(1):101-102. doi: 10.4314/ejhs.v28i1.13.
7
The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.在发病年龄较大的类风湿关节炎患者中,抗环瓜氨酸肽抗体(ACPA)的患病率较低,但ACPA反应的组成似乎相同。
Arthritis Res Ther. 2017 May 31;19(1):115. doi: 10.1186/s13075-017-1324-y.
8
[Diagnostics and treatment of polymyalgia rheumatica].[风湿性多肌痛的诊断与治疗]
Z Rheumatol. 2016 Sep;75(7):687-700. doi: 10.1007/s00393-016-0105-3.
9
Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.针对老年发病类风湿关节炎的低疾病活动度:生物改善病情抗风湿药的当前及未来作用
Drugs Aging. 2016 Feb;33(2):97-107. doi: 10.1007/s40266-015-0341-2.
10
Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.风湿性多肌痛的诊断与治疗进展及挑战
Ther Adv Musculoskelet Dis. 2014 Feb;6(1):8-19. doi: 10.1177/1759720X13512450.